SCHEMBL7877460

SCHEMBL7877460

CNC(N)=NC(=O)c1cc2cccc(OCc3ccccc3CN(C)C)c2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
FLT3 P36888 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTR7 P34969 1/20 0.33
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
FDPS P14324 1/20 0.33
HPGD P15428 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884463 0.91 MEN1 (0.38) MEN1KMT2AFLT3ALDH1A1TSHR
SCHEMBL7884787 0.90 MEN1 (0.39) MEN1KMT2AFLT3ALDH1A1HTR7
SCHEMBL7878089 0.89 SLC6A4 (0.41)
SCHEMBL7873771 0.88 ALDH1A1 (0.37) MEN1KMT2AFLT3ALDH1A1MTNR1A
SCHEMBL7880990 0.87 MGMT (0.38) FLT3ALDH1A1L3MBTL1IDO1HRH4
SCHEMBL7881388 0.85 MAPT (0.38) MEN1KMT2AFLT3ALDH1A1TSHR
SCHEMBL7879982 0.85 FLT3 (0.33) FLT3HDAC3HDAC1MTNR1AMTNR1B
SCHEMBL7878284 0.85 HRH3 (0.37) TSHR
SCHEMBL7878064 0.84 FFAR1 (0.36) KMT2A
Hydrochloric Acid SCHEMBL7877865 0.84 SRD5A2 (0.44) MEN1KMT2AALDH1A1MAPTIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed